A Randomized, Double-Blind, Third-Party-Unblinded, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AZD6423 in Healthy Volunteers

Trial Profile

A Randomized, Double-Blind, Third-Party-Unblinded, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AZD6423 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2014

At a glance

  • Drugs AZD 6423 (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 03 Apr 2014 Status changed from recruiting to completed as reoprted by ClinicalTrials.gov.
    • 01 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top